Natalie Memoli

1.0k total citations · 1 hit paper
7 papers, 868 citations indexed

About

Natalie Memoli is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Natalie Memoli has authored 7 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Natalie Memoli's work include Lung Cancer Treatments and Mutations (5 papers), Cancer-related Molecular Pathways (2 papers) and HER2/EGFR in Cancer Research (2 papers). Natalie Memoli is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Cancer-related Molecular Pathways (2 papers) and HER2/EGFR in Cancer Research (2 papers). Natalie Memoli collaborates with scholars based in United States, Canada and United Kingdom. Natalie Memoli's co-authors include Mark G. Kris, Vincent A. Miller, Maureen F. Zakowski, Barbara Pizzo, Robert T. Heelan, Jyoti D. Patel, Leslie B. Tyson, Ennapadam Venkatraman, Valerie W. Rusch and Christopher G. Azzoli and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Natalie Memoli

7 papers receiving 840 citations

Hit Papers

Bronchioloalveolar Pathologic Subtype and Smoking History... 2004 2026 2011 2018 2004 200 400 600

Peers

Natalie Memoli
Natalie Memoli
Citations per year, relative to Natalie Memoli Natalie Memoli (= 1×) peers Miguel Tarón

Countries citing papers authored by Natalie Memoli

Since Specialization
Citations

This map shows the geographic impact of Natalie Memoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Memoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Memoli more than expected).

Fields of papers citing papers by Natalie Memoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie Memoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Memoli. The network helps show where Natalie Memoli may publish in the future.

Co-authorship network of co-authors of Natalie Memoli

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie Memoli. A scholar is included among the top collaborators of Natalie Memoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie Memoli. Natalie Memoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Sarkaria, Inderpal S., DuyKhanh Pham, Ronald Ghossein, et al.. (2004). SCCRO Expression Correlates With Invasive Progression in Bronchioloalveolar Carcinoma. The Annals of Thoracic Surgery. 78(5). 1734–1741. 16 indexed citations
2.
Petty, W. Jeffrey, Konstantin H. Dragnev, Vincent A. Memoli, et al.. (2004). Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Represses Cyclin D1 in Aerodigestive Tract Cancers. Clinical Cancer Research. 10(22). 7547–7554. 78 indexed citations
3.
Pitha, Ian, W. Jeffrey Petty, Qing Feng, et al.. (2004). Microarray Analyses Uncover UBE1L as a Candidate Target Gene for Lung Cancer Chemoprevention. Cancer Research. 64(21). 8109–8115. 39 indexed citations
4.
Miller, Vincent A., Mark G. Kris, Neelam Shah, et al.. (2004). Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 22(6). 1103–1109. 628 indexed citations breakdown →
6.
Miller, Vincent A., Neelam Shah, Mark G. Kris, et al.. (2003). O-241 Clinical, pathologic, and molecular characteristics of NSCLC patients sensitive to gefitinib. Lung Cancer. 41. S71–S71. 4 indexed citations
7.
Lonardo, Fulvio, Konstantin H. Dragnev, Sarah J. Freemantle, et al.. (2002). Evidence for the epidermal growth factor receptor as a target for lung cancer prevention.. PubMed. 8(1). 54–60. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026